VICKI HYATT: Open Payments
NPI 1568842896 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 71 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,079 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $412 |
| Lilly USA, LLC | 10 | $222 |
| PFIZER INC. | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Abbott Laboratories | 4 | $82 |
| ABBVIE INC. | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Dexcom, Inc. | 2 | $53 |
| Almatica Pharma LLC | 2 | $48 |
| Exact Sciences Corporation | 3 | $48 |
Products named: Ozempic, MOUNJARO, Wegovy, FREESTYLE LIBRE 3, NURTEC ODT, JARDIANCE, AIRSUPRA, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
